Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cowan

Showing results (861-870 of 1,002) with videos related to

Pageof 101
Sort By:
ALTEX|November 28, 2025
The Merck 3 Baskets approach for creating roadmaps to phase out animal testingKerstin Kleinschmidt-Doerr, Frederic C Pipp, Isabelle Colmagne-Poulard, et al.
Bioanalysis|March 19, 2026
From 3-Tier to adaptive immunogenicity testing strategies: recommendations from the European Bioanalysis ForumKyra J Cowan, Rob Nelson, Annelies Coddens, et al.
Cell Metabolism|July 2, 2019
Metabolite Exchange between Mammalian Organs Quantified in PigsCholsoon Jang, Sheng Hui, Xianfeng Zeng, et al.
Transplantation|July 26, 2000
Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboonsP J Cowan, A Aminian, H Barlow, et al.
Transplantation Proceedings|November 22, 2011
Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboonsS Le Bas-Bernardet, X Tillou, N Poirier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 18, 2002
Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantationP J Cowan, A Aminian, H Barlow, et al.
JCO Oncology Practice|May 6, 2020
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle StrategyMary-Elizabeth M Percival, Ryan C Lynch, Anna B Halpern, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Cell Metabolism|June 4, 2019
A PRDM16-Driven Metabolic Signal from Adipocytes Regulates Precursor Cell FateWenshan Wang, Jeff Ishibashi, Sophie Trefely, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2008
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needsLinda M Griffith, Morton J Cowan, Donald B Kohn, et al.
Pageof 101

Showing results (861-870 of 1,002) with videos related to

Sort By:
Pageof 101
ALTEX|November 28, 2025
The Merck 3 Baskets approach for creating roadmaps to phase out animal testingKerstin Kleinschmidt-Doerr, Frederic C Pipp, Isabelle Colmagne-Poulard, et al.
Bioanalysis|March 19, 2026
From 3-Tier to adaptive immunogenicity testing strategies: recommendations from the European Bioanalysis ForumKyra J Cowan, Rob Nelson, Annelies Coddens, et al.
Cell Metabolism|July 2, 2019
Metabolite Exchange between Mammalian Organs Quantified in PigsCholsoon Jang, Sheng Hui, Xianfeng Zeng, et al.
Transplantation|July 26, 2000
Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboonsP J Cowan, A Aminian, H Barlow, et al.
Transplantation Proceedings|November 22, 2011
Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboonsS Le Bas-Bernardet, X Tillou, N Poirier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 18, 2002
Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantationP J Cowan, A Aminian, H Barlow, et al.
JCO Oncology Practice|May 6, 2020
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle StrategyMary-Elizabeth M Percival, Ryan C Lynch, Anna B Halpern, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Cell Metabolism|June 4, 2019
A PRDM16-Driven Metabolic Signal from Adipocytes Regulates Precursor Cell FateWenshan Wang, Jeff Ishibashi, Sophie Trefely, et al.
The Journal of Allergy and Clinical Immunology|November 11, 2008
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needsLinda M Griffith, Morton J Cowan, Donald B Kohn, et al.
Pageof 101